Genetic engineering

Genetic engineering is the deliberate modification of an organism's genetic material — usually its DNA — to introduce new traits, alter existing ones, or move specific genetic content from one organism to another. It emerged in its modern form in the early 1970s, when the recombinant-DNA work of Paul Berg, Stanley Cohen, and Herbert Boyer made it possible to cut, join, and copy genes at will, and it has since become the foundation of contemporary biotechnology. Its methods now reach from routine laboratory cloning to the precise, programmable genome editing introduced by CRISPR-Cas9 in 2012.

For the Wheel of Heaven framework, genetic engineering is more than one science among many. The framework's account of the origin of terrestrial life — that the Elohim designed and assembled it in laboratories, humanity included — is, in plain terms, a claim about genetic engineering carried out at a scale and sophistication far beyond the present state of the art. Contemporary biology, on this reading, is recovering a capability the Elohim already possessed. This entry sets out the discipline as it actually stands before turning to that reading, and keeps the line clear between what the science establishes and what the framework adds.

The science

Genetic engineering rests on a handful of enabling discoveries and a toolkit of natural enzymes repurposed for deliberate use. Its history is unusually well-dated, and the reasons for pausing over its risks were built into the discipline from the start.

Recombinant DNA and the founding period

Through the 1940s–1960s, molecular biology established the ground the discipline would stand on: that DNA carries hereditary information (Avery, MacLeod, and McCarty, 1944; Hershey and Chase, 1952), that it has a double-helix structure (Watson and Crick, 1953, built on Rosalind Franklin's X-ray diffraction data), and that its code could be read (the cracking of the genetic code, 1961–1966). What was still missing was any way to modify DNA deliberately.

That capability arrived in 1972–1973. Paul Berg, at Stanford, produced the first recombinant DNA molecule by splicing together DNA from two different sources. Stanley Cohen (Stanford) and Herbert Boyer (UC San Francisco) then showed that such engineered DNA could be inserted into bacteria that would copy and express it — the Cohen-Boyer technique, still the practical foundation of the field. The toolkit that made this work was assembled from natural molecules: restriction enzymes (Arber, Nathans, and Smith; Nobel Prize 1978) that cut DNA at defined sequences, DNA ligase to rejoin fragments, plasmids as vectors to carry genes into cells, the polymerase chain reaction (Kary Mullis, 1983) to amplify DNA, and Sanger sequencing (Frederick Sanger, 1977) to read it back.

As the technique spread, its practitioners paused over the hazards. In 1974 Berg and colleagues called for a voluntary moratorium on certain classes of experiment, and in February 1975 roughly 140 scientists met at the Asilomar Conference in California to set containment guidelines before proceeding. Asilomar is widely regarded as a rare instance of a research field confronting the risks of its own work before harm occurred; it shaped the NIH recombinant-DNA guidelines (1976) and the broader regulatory framework that followed. Commercial development moved quickly behind it — Genentech was founded in 1976, and recombinant human insulin reached patients in 1982.

The CRISPR era

The field's second transformation came in 2012. CRISPR-Cas9, adapted from a bacterial immune system by Jennifer Doudna and Emmanuelle Charpentier, gave biologists a programmable way to cut DNA at almost any chosen sequence, using a short guide RNA to steer the Cas9 enzyme to its target. Feng Zhang and George Church demonstrated the following year that it worked in mammalian cells. Cheaper, faster, and more precise than the earlier zinc-finger and TALEN methods, CRISPR became the dominant genome-editing platform within a few years; Doudna and Charpentier received the Nobel Prize in Chemistry in 2020, unusually soon after the discovery.

Refinements followed. Base editing and prime editing (David Liu, 2016 and 2019) make single-letter changes without cutting both DNA strands; variant systems such as Cas12 and Cas13 widen the range of targets. The first CRISPR therapy, Casgevy, was approved in late 2023 for sickle cell disease and transfusion-dependent beta-thalassemia. These are genuine, current capabilities — but they remain constrained. Off-target edits, incomplete editing that leaves cells with mixed genotypes, and immune responses to the editing machinery are all active problems, and the long-term consequences of permanent genome changes are not fully predictable.

Synthetic biology and applications

Genetic engineering has branched into related fields, each treated in its own entry: synthetic biology (engineering biological systems from standardised parts), synthetic genomics (designing and synthesising whole genomes), and pantropy (engineering organisms for non-terrestrial environments); the life engineering entry treats the umbrella concept. The applications are already broad — recombinant drugs and vaccines, including the mRNA COVID-19 vaccines; gene therapies for inherited disease, and CAR-T treatments for cancer; genetically modified crops; engineered enzymes, biofuels, and bioplastics. What the discipline cannot yet do is design a complex organism from scratch: it edits and recombines existing life far more readily than it builds new life. That boundary matters for the reading that follows.

The Wheel of Heaven reading

The framework's account of terrestrial life is, in the vocabulary of contemporary science, a claim about genetic engineering — carried out long ago, by others, at a scale biology has not approached.

On the reading developed from the Raëlian source material, life on Earth did not arise from unguided chemistry. It was designed and synthesised by the Elohim, an advanced civilization from a world outside the solar system, who assembled terrestrial plants, animals, and finally humanity in laboratories and released them into a prepared biosphere. The Genesis creation account is read as a compressed and partly garbled record of that project: the "days" of creation as ordered phases of engineering work, and the making of humanity "in our image" — the plural Elohim speaking of themselves — as the deliberate design of a species modelled on its makers. Eden is read as the enclosed laboratory where the first human lineage was synthesised, instructed, and observed. These are foundational claims of the framework, stated here as the corpus states them, and not endorsed by mainstream science.

What the framework adds to contemporary biology is a claimed history and a named agent. Where directed panspermia — the 1973 hypothesis of Francis Crick and Leslie Orgel that life was deliberately seeded from elsewhere — leaves the seeding civilization abstract, the corpus supplies the makers, the method (genetic design and laboratory synthesis), and a claimed contact record. The convergence in vocabulary is real: two of the leading molecular biologists of the twentieth century entertained the general shape of the claim. The framework does not pretend they endorse its specifics. The point is narrower and worth stating carefully — science has independently raised the general possibility of engineered life, even as it rejects the framework's particular account. The broader design question is developed in the Intelligent design entry.

Contemporary engineering as recovery. The framework reads today's genetic engineering as humanity recovering, on its own, the kind of capability the Elohim used at the creation. The double helix in 1953, recombinant DNA in the early 1970s, and CRISPR in 2012 are read as milestones along that recovery. On the corpus's chronology the acceleration belongs to the present transitional period — the Apocalypse, coextensive with the Age of Aquarius — in which humanity approaches the threshold of creating life itself. The Raëlian material, published in 1974–1976 just as recombinant DNA was emerging, anticipates that humanity will one day make life in laboratories as its makers did: the point at which, in the source's formulation, the created becomes a creator in turn. The relationship to the anticipated Great Return is read as preparation — current capability is the ground on which the Elohim's far greater knowledge could build. The name of the discipline preserves the connection the framework presses: genetic derives from the Greek génesis, "origin, generation," the same word that titles the creation account it reads as an engineering record.

The withheld knowledge. The framework's reading of Genesis places engineering knowledge at the centre of the Eden story. The Tree of the Knowledge of Good and Evil is read as the Elohim's own body of scientific knowledge, withheld from the first humans by order of the home-world Council of the Eternals so that the creation would not become the creators' equal. The disclosure narrated in Genesis 3 — the serpent's counsel — is read as the act of the Lucifer faction: a minority of the creators who judged the containment order unjust and gave their creation access to what it had been denied, and who were exiled to Earth for it. The canon insists on keeping this figure precise, because later tradition blurred it. The disclosing, preservationist faction is Lucifer's, and it is distinct from Satan, who led a separate faction holding that the whole human project was a mistake and should be abolished. The two are political opposites — Lucifer sought to empower humanity, Satan to end it — and the later Christian collapse of both into a single "devil" erases a real division within the creator civilization. On this reading, humanity's present mastery of genetic engineering is the long completion of the knowledge Lucifer's faction first began to hand over.

Ethical and critical perspectives

The framework's creation claim is a minority position, and the distinction between it and the science whose vocabulary it borrows deserves to be stated plainly. Mainstream biology treats the origin of life as an open but naturalistic question — abiogenesis on the early Earth, with no designer. That remains the more parsimonious hypothesis, because a designing civilization only relocates the origin problem: the designers then need explaining in turn, and each such move adds an unobserved civilization without shrinking the mystery. There is no independent physical evidence — no laboratory signature, no artefact, no confirmed contact — for an engineered origin of terrestrial life. The corpus rests its case on a reading of ancient texts and a contact narrative that science does not accept as data, and it does not claim otherwise. What it claims is narrower: that science has itself raised the general possibility of deliberate design, and that the framework states its own commitments openly and keeps them distinct from what has been demonstrated.

The ethics of the real discipline are contested on their own terms, and the framework reads that debate as part of the same story of recovered capability. Asilomar set an early precedent for self-regulation. The 1999 death of Jesse Gelsinger in a University of Pennsylvania gene-therapy trial — caused by a violent immune reaction to the viral vector, amid inadequate consent and undisclosed conflicts of interest — set the field back by roughly a decade. The long public argument over genetically modified crops turns on environmental impact, corporate concentration in the seed market, and consumer choice more than on any demonstrated health risk, which the scientific consensus has not found. The sharpest recent case is the He Jiankui affair: in November 2018 the Chinese biophysicist announced the birth of twin girls whose embryos he had edited with CRISPR — without medical necessity, adequate consent, or preclinical validation, and using forged ethical review. He was imprisoned, and the episode hardened an international consensus against heritable human genome editing, which nearly all jurisdictions prohibit for clinical use. The framework reads this ethical engagement — the moratoria, the regulation, the self-correction — not as an obstacle but as evidence of a humanity learning to hold a powerful capability responsibly, the disposition the source material treats as the precondition for the larger inheritance the Great Return anticipates.

The real convergence between the framework and the science is narrow, and worth holding onto. Both take the origin and design of life to be a genuine, unsettled, and consequential question. They differ on whether it has already been answered — and on whether the answer is written in the genome or in the texts.

See also

• Genesis Toolbox
• Life engineering
• Synthetic biology
• Synthetic genomics
• Pantropy
• Intelligent design
• Genesis
• Eden
• Tree of the Knowledge of Good and Evil
• Elohim
• Adamites
• Great Return
• Apocalypse
• Cosmic Chain
• List of etymological readings
• List of exegetic readings
• Terraforming

External links

• Genetic engineering | Wikipedia
• CRISPR | Wikipedia
• Asilomar Conference on Recombinant DNA | Wikipedia
• Recombinant DNA | Wikipedia
• Genetically modified organism | Wikipedia
• Gene therapy | Wikipedia
• He Jiankui affair | Wikipedia

References

Vorilhon, Claude (Raël). Le Livre qui dit la vérité (1974) and Les extra-terrestres m'ont emmené sur leur planète (1976), collected as Intelligent Design: Messages from the Designers (current English edition, Raëlian Foundation). [Primary source for the framework's reading of the Elohim's original genetic-engineering work and the broader contemporary recovery anticipation.]

Berg, Paul, David Baltimore, Sydney Brenner, Richard O. Roblin III, and Maxine F. Singer. "Asilomar Conference on Recombinant DNA Molecules." Science 188, no. 4192 (June 6, 1975): 991–994. [The foundational publication of the Asilomar Conference recommendations.]

Berg, Paul. "Asilomar 1975: DNA modification secured." Nature 455, no. 7211 (September 18, 2008): 290–291. [Berg's retrospective on the Asilomar Conference.]

Cohen, Stanley N., Annie C. Y. Chang, Herbert W. Boyer, and Robert B. Helling. "Construction of biologically functional bacterial plasmids in vitro." Proceedings of the National Academy of Sciences 70, no. 11 (November 1973): 3240–3244. [The foundational Cohen-Boyer publication establishing recombinant DNA technology.]

Jinek, Martin, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A. Doudna, and Emmanuelle Charpentier. "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity." Science 337, no. 6096 (August 17, 2012): 816–821. [The foundational Doudna-Charpentier publication establishing CRISPR-Cas9 as a programmable genome-editing tool.]

Cong, Le, F. Ann Ran, David Cox, Shuailiang Lin, Robert Barretto, Naomi Habib, Patrick D. Hsu, Xuebing Wu, Wenyan Jiang, Luciano A. Marraffini, and Feng Zhang. "Multiplex genome engineering using CRISPR/Cas systems." Science 339, no. 6121 (February 15, 2013): 819–823. [The foundational Zhang publication establishing CRISPR-Cas9 for mammalian genome editing.]

Doudna, Jennifer A., and Samuel H. Sternberg. A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution. Houghton Mifflin Harcourt, 2017. [The principal accessible scientific autobiography by one of the principal CRISPR developers.]

Watson, James D., and Andrew Berry. DNA: The Secret of Life. Knopf, 2003. [The principal accessible scientific history of molecular biology and genetic engineering.]

Mukherjee, Siddhartha. The Gene: An Intimate History. Scribner, 2016. [The principal contemporary accessible history of genetics and genetic engineering.]

Krimsky, Sheldon. Genetic Alchemy: The Social History of the Recombinant DNA Controversy. MIT Press, 1982. [The principal scholarly history of the Asilomar-period controversies.]

Wright, Susan. Molecular Politics: Developing American and British Regulatory Policy for Genetic Engineering, 1972-1982. University of Chicago Press, 1994. [The standard scholarly history of the early regulatory development.]

Carroll, Sean B. The Making of the Fittest: DNA and the Ultimate Forensic Record of Evolution. Norton, 2006.

Venter, J. Craig. Life at the Speed of Light: From the Double Helix to the Dawn of Digital Life. Viking, 2013.

Church, George, and Ed Regis. Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves. Basic Books, 2012.

Davies, Kevin. Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing. Pegasus Books, 2020. [The principal contemporary scholarly history of the CRISPR era.]

Kirksey, Eben. The Mutant Project: Inside the Global Race to Genetically Modify Humans. St. Martin's Press, 2020. [The principal scholarly engagement with the He Jiankui affair.]

National Academies of Sciences, Engineering, and Medicine. Heritable Human Genome Editing. National Academies Press, 2020. [The principal contemporary international scientific community position on heritable genome editing.]

Biglino, Mauro. Il libro che cambierà per sempre le nostre idee sulla Bibbia. Mondadori, 2011. [Contemporary philological engagement with the Hebrew Bible's account of the Elohim's engineering work.]

Sendy, Jean. La Lune, clé de la Bible. Julliard, 1968.

Sendy, Jean. Ces dieux qui firent le ciel et la terre. Robert Laffont, 1969.

Wallis, Paul. Escaping from Eden: Does Genesis Teach That the Human Race Was Created by God or Engineered by ETs? 6th Books, 2020.

Doudna, Jennifer A., and Emmanuelle Charpentier. "The new frontier of genome engineering with CRISPR-Cas9." Science 346, no. 6213 (November 28, 2014): 1258096.

Lander, Eric S. "The Heroes of CRISPR." Cell 164, no. 1-2 (January 14, 2016): 18–28.

Anzalone, Andrew V., Peyton B. Randolph, Jessie R. Davis, Alexander A. Sousa, Luke W. Koblan, Jonathan M. Levy, Peter J. Chen, Christopher Wilson, Gregory A. Newby, Aditya Raguram, and David R. Liu. "Search-and-replace genome editing without double-strand breaks or donor DNA." Nature 576 (December 2019): 149–157. [The foundational publication on prime editing.]

"Genetic engineering." Wikipedia. https://en.wikipedia.org/wiki/Genetic_engineering

"CRISPR." Wikipedia. https://en.wikipedia.org/wiki/CRISPR

"Asilomar Conference on Recombinant DNA." Wikipedia. https://en.wikipedia.org/wiki/Asilomar_Conference_on_Recombinant_DNA

"Recombinant DNA." Wikipedia. https://en.wikipedia.org/wiki/Recombinant_DNA

"He Jiankui affair." Wikipedia. https://en.wikipedia.org/wiki/He_Jiankui_affair

"Cartagena Protocol on Biosafety." Wikipedia. https://en.wikipedia.org/wiki/Cartagena_Protocol_on_Biosafety

Genetic engineering. (2026). Wheel of Heaven. https://www.wheelofheaven.world/wiki/genetic-engineering/

"Genetic engineering." Wheel of Heaven, 2026, https://www.wheelofheaven.world/wiki/genetic-engineering/.

"Genetic engineering." Wheel of Heaven, 2026. https://www.wheelofheaven.world/wiki/genetic-engineering/.

@misc{woh-genetic-engineering,
  author       = {{Wheel of Heaven}},
  title        = {Genetic engineering},
  year         = {2026},
  howpublished = {\url{https://www.wheelofheaven.world/wiki/genetic-engineering/}},
  note         = {CC0-1.0 public domain}
}